PropertyValue
?:abstract
  • Hydroxychloroquine is an agent used as a treatment but also considered as a prophylaxis for SARS-CoV-2 infection We report the case of a patient who developed COVID-19 while on hydroxychloroquine for mixed connectivitis associated with spondyloarthritis Although more work is needed before any conclusions can be drawn, this raises questions about the protective role of this drug against infection Are they really protected against COVID-19 or will they develop pauci-symptomatic forms?
is ?:annotates of
?:creator
?:journal
  • The_Pan_African_medical_journal
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • [SARS-CoV-2 infection in a patient treated by hydroxychloroquine and anti TNF alpha for Inflammatory Rheumatic Disease]
?:type
?:who_covidence_id
  • #926732
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/zaawxujb>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/zaawxujb>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all